Feasibility of an Activity Control System in Patients with Diabetes: A Study Protocol of a Randomised Controlled Trial

Purpose: Patients with diabetes mellitus have an increased risk of developing various serious health problems that could be lifethreatening. These problems are associated with the difficulty of these patients in managing their lifestyle, which may even lead to the abandonment of treatment. The prese...

Full description

Saved in:
Bibliographic Details
Published in:Diabetes, metabolic syndrome and obesity Vol. 15; pp. 2683 - 2691
Main Authors: Montagut-Martínez, Pedro, García-Arenas, Jose Joaquin, Romero-López, Matilde, Rodríguez-Rodríguez, Nicomedes, Pérez-Cruzado, David, González-Lama, Jesús
Format: Journal Article
Language:English
Published: Macclesfield Dove Medical Press Limited 01-01-2022
Taylor & Francis Ltd
Dove
Dove Medical Press
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Purpose: Patients with diabetes mellitus have an increased risk of developing various serious health problems that could be lifethreatening. These problems are associated with the difficulty of these patients in managing their lifestyle, which may even lead to the abandonment of treatment. The present study was designed to evaluate the feasibility of a multipurpose activity control solution for home activity (home activity control system), which will provide information on the activities of daily living carried out outside in real time, to improve adherence to each of the therapeutic objectives agreed on with the diabetic patient. Patients and Methods: A pilot randomised controlled feasibility study will be carried out to evaluate a home activity control system (Beprevent) in managing patients with type 2 diabetes mellitus. Twenty patients with type 2 diabetes mellitus will be included (10 in the intervention group and 10 in the control group). Data on satisfaction with the tool will be collected from professionals and patients, as well as other clinical/epidemiological data from their digital health records and several questionnaires, at baseline and six months. In addition, data will also be recorded regarding the degree of adherence to the behaviors agreed on with the patients before starting the study to assess changes throughout the study and their relationship with clinical results (glycosylated haemoglobin (HbA1c), cholesterol, etc), and to compare these outcomes between two study groups. Discussion: This project involves the incorporation of telemedicine in the management of patients with diabetes. Thus, according to the currently published bibliography, the use of smart devices in this population could help improve the quality of life of these people, reduce medical visits and improve adherence to home care patterns for diabetes mellitus. There are currently no published clinical trials or protocols that monitor activities of daily living in patients with diabetes individually using artificial intelligence (AI) devices. Keywords: artificial intelligence, diabetes mellitus, self-care, telemedicine
AbstractList Pedro Montagut-Martínez,1 Jose Joaquin García-Arenas,2 Matilde Romero-López,3 Nicomedes Rodríguez-Rodríguez,3 David Pérez-Cruzado,2,4 Jesús González-Lama3,5 1Health Sciences PhD Program, Universidad Católica de Murcia UCAM, Murcia, 30107, Spain; 2Department of Occupational Therapy, Universidad Catolica de Murcia UCAM, Murcia, 30107, Spain; 3Cabra Clinical Management Unit, Sur de Córdoba Health Management Area, Cordoba, Spain; 4Institute of Biomedicine of Malaga (IBIMA), Málaga, Spain; 5Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Cordoba, SpainCorrespondence: David Pérez-Cruzado, Department of Occupational Therapy, Universidad Catolica de Murcia UCAM, Campus de los Jerónimos n° 135, Guadalupe, Murcia, 30107, Spain, Tel +34 653141109, Email d_perez_cruzado@hotmail.comPurpose: Patients with diabetes mellitus have an increased risk of developing various serious health problems that could be life-threatening. These problems are associated with the difficulty of these patients in managing their lifestyle, which may even lead to the abandonment of treatment. The present study was designed to evaluate the feasibility of a multipurpose activity control solution for home activity (home activity control system), which will provide information on the activities of daily living carried out outside in real time, to improve adherence to each of the therapeutic objectives agreed on with the diabetic patient.Patients and Methods: A pilot randomised controlled feasibility study will be carried out to evaluate a home activity control system (Beprevent) in managing patients with type 2 diabetes mellitus. Twenty patients with type 2 diabetes mellitus will be included (10 in the intervention group and 10 in the control group). Data on satisfaction with the tool will be collected from professionals and patients, as well as other clinical/epidemiological data from their digital health records and several questionnaires, at baseline and six months. In addition, data will also be recorded regarding the degree of adherence to the behaviors agreed on with the patients before starting the study to assess changes throughout the study and their relationship with clinical results (glycosylated haemoglobin (HbA1c), cholesterol, etc), and to compare these outcomes between two study groups.Discussion: This project involves the incorporation of telemedicine in the management of patients with diabetes. Thus, according to the currently published bibliography, the use of smart devices in this population could help improve the quality of life of these people, reduce medical visits and improve adherence to home care patterns for diabetes mellitus. There are currently no published clinical trials or protocols that monitor activities of daily living in patients with diabetes individually using artificial intelligence (AI) devices.Keywords: artificial intelligence, diabetes mellitus, self-care, telemedicine
Purpose: Patients with diabetes mellitus have an increased risk of developing various serious health problems that could be lifethreatening. These problems are associated with the difficulty of these patients in managing their lifestyle, which may even lead to the abandonment of treatment. The present study was designed to evaluate the feasibility of a multipurpose activity control solution for home activity (home activity control system), which will provide information on the activities of daily living carried out outside in real time, to improve adherence to each of the therapeutic objectives agreed on with the diabetic patient. Patients and Methods: A pilot randomised controlled feasibility study will be carried out to evaluate a home activity control system (Beprevent) in managing patients with type 2 diabetes mellitus. Twenty patients with type 2 diabetes mellitus will be included (10 in the intervention group and 10 in the control group). Data on satisfaction with the tool will be collected from professionals and patients, as well as other clinical/epidemiological data from their digital health records and several questionnaires, at baseline and six months. In addition, data will also be recorded regarding the degree of adherence to the behaviors agreed on with the patients before starting the study to assess changes throughout the study and their relationship with clinical results (glycosylated haemoglobin (HbA1c), cholesterol, etc), and to compare these outcomes between two study groups. Discussion: This project involves the incorporation of telemedicine in the management of patients with diabetes. Thus, according to the currently published bibliography, the use of smart devices in this population could help improve the quality of life of these people, reduce medical visits and improve adherence to home care patterns for diabetes mellitus. There are currently no published clinical trials or protocols that monitor activities of daily living in patients with diabetes individually using artificial intelligence (AI) devices. Keywords: artificial intelligence, diabetes mellitus, self-care, telemedicine
Purpose: Patients with diabetes mellitus have an increased risk of developing various serious health problems that could be life-threatening. These problems are associated with the difficulty of these patients in managing their lifestyle, which may even lead to the abandonment of treatment. The present study was designed to evaluate the feasibility of a multipurpose activity control solution for home activity (home activity control system), which will provide information on the activities of daily living carried out outside in real time, to improve adherence to each of the therapeutic objectives agreed on with the diabetic patient. Patients and Methods: A pilot randomised controlled feasibility study will be carried out to evaluate a home activity control system (Beprevent) in managing patients with type 2 diabetes mellitus. Twenty patients with type 2 diabetes mellitus will be included (10 in the intervention group and 10 in the control group). Data on satisfaction with the tool will be collected from professionals and patients, as well as other clinical/epidemiological data from their digital health records and several questionnaires, at baseline and six months. In addition, data will also be recorded regarding the degree of adherence to the behaviors agreed on with the patients before starting the study to assess changes throughout the study and their relationship with clinical results (glycosylated haemoglobin (HbA1c), cholesterol, etc), and to compare these outcomes between two study groups. Discussion: This project involves the incorporation of telemedicine in the management of patients with diabetes. Thus, according to the currently published bibliography, the use of smart devices in this population could help improve the quality of life of these people, reduce medical visits and improve adherence to home care patterns for diabetes mellitus. There are currently no published clinical trials or protocols that monitor activities of daily living in patients with diabetes individually using artificial intelligence (AI) devices.
PurposePatients with diabetes mellitus have an increased risk of developing various serious health problems that could be life-threatening. These problems are associated with the difficulty of these patients in managing their lifestyle, which may even lead to the abandonment of treatment. The present study was designed to evaluate the feasibility of a multipurpose activity control solution for home activity (home activity control system), which will provide information on the activities of daily living carried out outside in real time, to improve adherence to each of the therapeutic objectives agreed on with the diabetic patient. Patients and MethodsA pilot randomised controlled feasibility study will be carried out to evaluate a home activity control system (Beprevent) in managing patients with type 2 diabetes mellitus. Twenty patients with type 2 diabetes mellitus will be included (10 in the intervention group and 10 in the control group). Data on satisfaction with the tool will be collected from professionals and patients, as well as other clinical/epidemiological data from their digital health records and several questionnaires, at baseline and six months. In addition, data will also be recorded regarding the degree of adherence to the behaviors agreed on with the patients before starting the study to assess changes throughout the study and their relationship with clinical results (glycosylated haemoglobin (HbA1c), cholesterol, etc), and to compare these outcomes between two study groups. DiscussionThis project involves the incorporation of telemedicine in the management of patients with diabetes. Thus, according to the currently published bibliography, the use of smart devices in this population could help improve the quality of life of these people, reduce medical visits and improve adherence to home care patterns for diabetes mellitus. There are currently no published clinical trials or protocols that monitor activities of daily living in patients with diabetes individually using artificial intelligence (AI) devices.
Audience Academic
Author García-Arenas, Jose Joaquin
Rodríguez-Rodríguez, Nicomedes
Pérez-Cruzado, David
Romero-López, Matilde
Montagut-Martínez, Pedro
González-Lama, Jesús
Author_xml – sequence: 1
  givenname: Pedro
  orcidid: 0000-0002-8698-6231
  surname: Montagut-Martínez
  fullname: Montagut-Martínez, Pedro
– sequence: 2
  givenname: Jose Joaquin
  surname: García-Arenas
  fullname: García-Arenas, Jose Joaquin
– sequence: 3
  givenname: Matilde
  surname: Romero-López
  fullname: Romero-López, Matilde
– sequence: 4
  givenname: Nicomedes
  surname: Rodríguez-Rodríguez
  fullname: Rodríguez-Rodríguez, Nicomedes
– sequence: 5
  givenname: David
  orcidid: 0000-0001-7952-0831
  surname: Pérez-Cruzado
  fullname: Pérez-Cruzado, David
– sequence: 6
  givenname: Jesús
  surname: González-Lama
  fullname: González-Lama, Jesús
BookMark eNptkk1vEzEQhleoiJbSGz_AEhLiQII_114OSFFKoVJRK1LOltdrJ442drG9Qfn3eEmABmEfPB6_84z8ap5XJz54U1UvEZxiRPm7yy-L2-mC1A2t6ZPqDCEuJhxCfvIoPq0uUlrDcXFIMX5WnZIaClQjdlZtr4xKrnW9yzsQLFAezHR22_E6Dz7H0IPFLmWzAc6DO5Wd8TmBHy6vwKVTrckmvQczsMhDtwN3MeSgS8lIAl-V78LGJdP9RvUlvI9O9S-qp1b1yVwczvPq29XH-_nnyc3tp-v57GaiGYJ5QoWhVmNqUWcV1rzjihBDmaa60ZZZSzW03OKmgYyZthMQG65ZjVnTkppScl5d77ldUGv5EN1GxZ0MyslfiRCXUsXsdG8kJJgjaJERClFtbduYlmpGYMO6tuO2sD7sWQ9DuzGdLkZE1R9Bj1-8W8ll2MqGUkEYKoA3B0AM3weTsizmaNP3ypswJFn6Y0FrRkmRvvpHug5D9MWqUcUQ40Kgv6qlKh9w3obSV49QOeOYYCKYEEU1_Y-q7M5snC7zZF3JHxW8flSwMqrPqxT6Ibvg07Hw7V6oY0gpGvvHDATlOJ9ynE95mE_yE9w61vQ
Cites_doi 10.1089/dia.2020.0656
10.2337/dc19-2519
10.1370/afm.2421
10.1249/01.MSS.0000078924.61453.FB
10.2196/18119
10.1016/S1138-6045(07)73665-1
10.1016/j.aprim.2015.08.005
10.1080/03091902.2022.2089249
10.1016/0021-9681(87)90171-8
10.1097/00005650-198601000-00007
10.1900/RDS.2010.7.252
10.1111/bcp.12194
10.1016/S2213-8587(18)30051-2
10.2196/29178
10.3390/ijerph19106128
10.1111/dme.13958
10.1590/1980-220x-reeusp-2021-0295
10.2337/dc16-0614
10.1186/1471-2458-9-31
10.2196/31832
10.2337/diacare.24.1.16
10.1080/10408398.2010.500258
10.1136/bmj.e7586
10.1177/0145721720913276
10.1016/S2213-8587(18)30203-1
10.1016/j.diabres.2018.02.023
ContentType Journal Article
Copyright COPYRIGHT 2022 Dove Medical Press Limited
2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2022 Montagut-Martínez et al. 2022 Montagut-Martínez et al.
Copyright_xml – notice: COPYRIGHT 2022 Dove Medical Press Limited
– notice: 2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2022 Montagut-Martínez et al. 2022 Montagut-Martínez et al.
DBID AAYXX
CITATION
3V.
7RV
7XB
8C1
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
COVID
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
KB0
M2O
MBDVC
NAPCQ
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.2147/DMSO.S369464
DatabaseName CrossRef
ProQuest Central (Corporate)
Nursing & Allied Health Database (ProQuest)
ProQuest Central (purchase pre-March 2016)
ProQuest Public Health Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
Coronavirus Research Database
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
Nursing & Allied Health Database (Alumni Edition)
ProQuest research library
Research Library (Corporate)
Nursing & Allied Health Premium
Publicly Available Content Database (Proquest) (PQ_SDU_P3)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle CrossRef
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
ProQuest Central (Alumni Edition)
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Central China
ProQuest Central
Health Research Premium Collection
ProQuest Central Korea
ProQuest Research Library
ProQuest Public Health
ProQuest Central Basic
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

Publicly Available Content Database

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: http://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Montagut-Martínez et al
EISSN 1178-7007
EndPage 2691
ExternalDocumentID oai_doaj_org_article_032710f1e8a14cffb9eb4c53095dbd7f
A723238588
10_2147_DMSO_S369464
GeographicLocations Spain
GeographicLocations_xml – name: Spain
GrantInformation_xml – fundername: ;
GroupedDBID ---
0YH
29F
2WC
53G
5VS
7RV
8C1
8FI
8FJ
8G5
AAYXX
ABUWG
ACGFO
ADBBV
ADRAZ
AFKRA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BCNDV
BENPR
BKEYQ
BPHCQ
BVXVI
C1A
CCPQU
CITATION
DIK
DWQXO
E3Z
EBD
EBS
EJD
FYUFA
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
HYE
IAO
IHR
IHW
IPNFZ
ITC
KQ8
M2O
M48
M~E
NAPCQ
O5R
O5S
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
RIG
RNS
RPM
TDBHL
TR2
UKHRP
VDV
3V.
7XB
8FK
COVID
MBDVC
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c510t-48e4fc24f1dfa2c7d7a33e45c4c9cf5ff4c0f7f299055ebd802e7c56259b36443
IEDL.DBID RPM
ISSN 1178-7007
IngestDate Tue Oct 22 15:14:48 EDT 2024
Tue Sep 17 21:25:17 EDT 2024
Fri Aug 16 23:57:21 EDT 2024
Fri Nov 08 02:17:29 EST 2024
Tue Nov 19 21:06:41 EST 2024
Tue Nov 12 22:55:19 EST 2024
Tue Aug 20 22:13:23 EDT 2024
Thu Nov 21 23:52:06 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c510t-48e4fc24f1dfa2c7d7a33e45c4c9cf5ff4c0f7f299055ebd802e7c56259b36443
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-7952-0831
0000-0002-8698-6231
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448351/
PMID 36081615
PQID 2715157881
PQPubID 3933170
PageCount 9
ParticipantIDs doaj_primary_oai_doaj_org_article_032710f1e8a14cffb9eb4c53095dbd7f
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9448351
proquest_miscellaneous_2712846543
proquest_journals_2715157881
gale_infotracmisc_A723238588
gale_infotracacademiconefile_A723238588
gale_healthsolutions_A723238588
crossref_primary_10_2147_DMSO_S369464
PublicationCentury 2000
PublicationDate 2022-01-01
PublicationDateYYYYMMDD 2022-01-01
PublicationDate_xml – month: 01
  year: 2022
  text: 2022-01-01
  day: 01
PublicationDecade 2020
PublicationPlace Macclesfield
PublicationPlace_xml – name: Macclesfield
PublicationTitle Diabetes, metabolic syndrome and obesity
PublicationYear 2022
Publisher Dove Medical Press Limited
Taylor & Francis Ltd
Dove
Dove Medical Press
Publisher_xml – name: Dove Medical Press Limited
– name: Taylor & Francis Ltd
– name: Dove
– name: Dove Medical Press
References Shankaracharya Odedra (ref8) 2010; 7
Baena-Díez (ref1) 2016; 39
May (ref12) 2021; 23
ref15
Craig (ref23) 2003; 35
Nguyen (ref19) 2014; 77
Fernandez (ref30) 1998; 10
Clark (ref16) 2020
Val Jiménez (ref20) 1992; 10
Torres (ref31) 2005; 33
Caro-Bautista (ref22) 2016; 48
Brooke (ref27) 1996; 189
Charlson (ref18) 1987; 40
Hills (ref2) 2018; 6
Morisky (ref21) 1986; 24
Cho (ref3) 2018; 138
Garg (ref13) 2021; 23
Garcia (ref17) 2001; 24
Moody (ref10) 2022
Brooke (ref26) 2013; 8
Jamal (ref7) 2021; 6
ref28
Correia (ref11) 2022; 19
ref29
Chan (ref14) 2013; 346
Seng (ref33) 2020; 43
Ahlqvist (ref34) 2018; 6
Dambha-Miller (ref5) 2019; 17
Negreiros (ref9) 2021; 55
Giné-Garriga (ref24) 2009; 9
Lazarou (ref4) 2012; 52
Mueller (ref6) 2022; 7
Mantilla Toloza (ref25) 2007; 10
Holt (ref32) 2019; 36
References_xml – volume: 23
  start-page: S15
  year: 2021
  ident: ref13
  publication-title: Diabetes Technol Ther
  doi: 10.1089/dia.2020.0656
  contributor:
    fullname: Garg
– volume: 43
  start-page: 1048
  year: 2020
  ident: ref33
  publication-title: Diabetes Care
  doi: 10.2337/dc19-2519
  contributor:
    fullname: Seng
– volume: 17
  start-page: 311
  year: 2019
  ident: ref5
  publication-title: Ann Fam Med
  doi: 10.1370/afm.2421
  contributor:
    fullname: Dambha-Miller
– volume: 35
  start-page: 1381
  year: 2003
  ident: ref23
  publication-title: Med Sci Sports Exerc
  doi: 10.1249/01.MSS.0000078924.61453.FB
  contributor:
    fullname: Craig
– volume: 23
  start-page: e18119
  year: 2021
  ident: ref12
  publication-title: J Med Internet Res
  doi: 10.2196/18119
  contributor:
    fullname: May
– volume: 10
  start-page: 48
  year: 2007
  ident: ref25
  publication-title: Revista Iberoamericana de Fisioterapia y Kinesiología
  doi: 10.1016/S1138-6045(07)73665-1
  contributor:
    fullname: Mantilla Toloza
– ident: ref29
– volume: 48
  start-page: 458
  year: 2016
  ident: ref22
  publication-title: Aten Primaria
  doi: 10.1016/j.aprim.2015.08.005
  contributor:
    fullname: Caro-Bautista
– start-page: 1
  year: 2022
  ident: ref10
  publication-title: J Med Eng Technol
  doi: 10.1080/03091902.2022.2089249
  contributor:
    fullname: Moody
– volume: 40
  start-page: 373
  year: 1987
  ident: ref18
  publication-title: J Chronic Dis
  doi: 10.1016/0021-9681(87)90171-8
  contributor:
    fullname: Charlson
– volume: 33
  start-page: 216
  year: 2005
  ident: ref31
  publication-title: Actas Esp Psiquiatr
  contributor:
    fullname: Torres
– volume: 10
  start-page: 767
  year: 1992
  ident: ref20
  publication-title: Aten Primaria
  contributor:
    fullname: Val Jiménez
– volume: 24
  start-page: 67
  year: 1986
  ident: ref21
  publication-title: Med Care
  doi: 10.1097/00005650-198601000-00007
  contributor:
    fullname: Morisky
– volume: 7
  start-page: 252
  year: 2010
  ident: ref8
  publication-title: Rev Diabet Stud
  doi: 10.1900/RDS.2010.7.252
  contributor:
    fullname: Shankaracharya Odedra
– volume: 77
  start-page: 427
  year: 2014
  ident: ref19
  publication-title: Br J Clin Pharmacol
  doi: 10.1111/bcp.12194
  contributor:
    fullname: Nguyen
– ident: ref15
– volume: 6
  start-page: 361
  year: 2018
  ident: ref34
  publication-title: Lancet Diabetes Endocrinol
  doi: 10.1016/S2213-8587(18)30051-2
  contributor:
    fullname: Ahlqvist
– volume: 6
  start-page: e29178
  year: 2021
  ident: ref7
  publication-title: JMIR Diabetes
  doi: 10.2196/29178
  contributor:
    fullname: Jamal
– volume: 19
  start-page: 6128
  year: 2022
  ident: ref11
  publication-title: Int J Environ Res Public Health
  doi: 10.3390/ijerph19106128
  contributor:
    fullname: Correia
– volume: 36
  start-page: 529
  year: 2019
  ident: ref32
  publication-title: Diabet Med
  doi: 10.1111/dme.13958
  contributor:
    fullname: Holt
– volume: 55
  start-page: e20210295
  year: 2021
  ident: ref9
  publication-title: Rev Esc Enferm USP
  doi: 10.1590/1980-220x-reeusp-2021-0295
  contributor:
    fullname: Negreiros
– volume: 39
  start-page: 1987
  year: 2016
  ident: ref1
  publication-title: Diabetes Care
  doi: 10.2337/dc16-0614
  contributor:
    fullname: Baena-Díez
– volume: 9
  start-page: 31
  year: 2009
  ident: ref24
  publication-title: BMC Public Health
  doi: 10.1186/1471-2458-9-31
  contributor:
    fullname: Giné-Garriga
– volume: 10
  start-page: 459
  year: 1998
  ident: ref30
  publication-title: Psicothema-Oviedo
  contributor:
    fullname: Fernandez
– volume: 7
  start-page: e31832
  year: 2022
  ident: ref6
  publication-title: JMIR Diabetes
  doi: 10.2196/31832
  contributor:
    fullname: Mueller
– ident: ref28
– volume: 8
  start-page: 29
  year: 2013
  ident: ref26
  publication-title: J Usability Stud
  contributor:
    fullname: Brooke
– volume: 189
  start-page: 4
  year: 1996
  ident: ref27
  publication-title: Usability Eval Ind
  contributor:
    fullname: Brooke
– volume: 24
  start-page: 16
  year: 2001
  ident: ref17
  publication-title: Diabetes Care
  doi: 10.2337/diacare.24.1.16
  contributor:
    fullname: Garcia
– volume: 52
  start-page: 382
  year: 2012
  ident: ref4
  publication-title: Crit Rev Food Sci Nutr
  doi: 10.1080/10408398.2010.500258
  contributor:
    fullname: Lazarou
– volume: 346
  start-page: e7586
  year: 2013
  ident: ref14
  publication-title: BMJ
  doi: 10.1136/bmj.e7586
  contributor:
    fullname: Chan
– start-page: 0145721720913276
  year: 2020
  ident: ref16
  publication-title: Diabetes Educ
  doi: 10.1177/0145721720913276
  contributor:
    fullname: Clark
– volume: 6
  start-page: 992
  year: 2018
  ident: ref2
  publication-title: Lancet Diabetes Endocrinol
  doi: 10.1016/S2213-8587(18)30203-1
  contributor:
    fullname: Hills
– volume: 138
  start-page: 271
  year: 2018
  ident: ref3
  publication-title: Diabetes Res Clin Pract
  doi: 10.1016/j.diabres.2018.02.023
  contributor:
    fullname: Cho
SSID ssj0000070422
Score 2.2960618
Snippet Purpose: Patients with diabetes mellitus have an increased risk of developing various serious health problems that could be lifethreatening. These problems are...
Purpose: Patients with diabetes mellitus have an increased risk of developing various serious health problems that could be life-threatening. These problems...
PurposePatients with diabetes mellitus have an increased risk of developing various serious health problems that could be life-threatening. These problems are...
Pedro Montagut-Martínez,1 Jose Joaquin García-Arenas,2 Matilde Romero-López,3 Nicomedes Rodríguez-Rodríguez,3 David Pérez-Cruzado,2,4 Jesús González-Lama3,5...
SourceID doaj
pubmedcentral
proquest
gale
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
StartPage 2683
SubjectTerms Activities of daily living
Artificial intelligence
Care and treatment
Clinical trials
Control systems
Diabetes
diabetes mellitus
Diabetes therapy
Diabetics
Glycosylated hemoglobin
Health aspects
Home care
Intervention
Medical records
Medical research
Medicine, Experimental
Nutrition research
Pathology
Patients
Questionnaires
self-care
Study Protocol
Telemedicine
Type 2 diabetes
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB6VHiouiPIQKS0YqYhTaOI4scNt6UO9tFRskbhZiR-iEkqq7i5S_z0ztnfVwIELtySeWMk84s_O-BuAQ6dUbbkq8t5InxMmz1tLyTS-4X1jW8sNLbidz-Xld3VySjQ5m1JflBMW6YGj4o6KiuMg6EunulIY7_vW9cLUFUID21vpw9e3aB5MpiLwlURuFSurqFziecx6p7I8RycX8y8f51XTikZMxqNA2__3x_nPhMkHI9DZU3iSoCObxUfehS03PIOdi_Rz_Dn8QjiXkl3v2ehZN7CZicUh2HHMSGeRoJzdDOwqEqouGK3EspQYs_jEZoxSC-_Z1d24HNFLQk_sazfYEV3C2XVXP_Hwmrz3BXw7O70-Ps9TWYXcYAAuc6Gc8IYLX1rfcSOt7KrKidoI0xpfey9M4aWncaquXW9VwZ00YaLUVwifqpewPYyDewWM-AN9KWxRdEI4X3StLC0R6remxK55Bu_XytW3kT1D46yDjKDJCDoZIYPPpPmNDHFehwvoCTp5gv6XJ2Twluym4wbSTeTqmUTUSP8_VQYfggTFLtrRdGkLAr4MsWBNJPcnkqhgM21e-4ZOMb_Q-HQIDomeP4N3m2a6k_LYBjeuggziAdrPm4Gc-NTk3actw82PwPvd4lS6qsu9_6Gs1_CY00aOsJi0D9vLu5U7gEcLu3oTIuk3648imA
  priority: 102
  providerName: Directory of Open Access Journals
Title Feasibility of an Activity Control System in Patients with Diabetes: A Study Protocol of a Randomised Controlled Trial
URI https://www.proquest.com/docview/2715157881
https://search.proquest.com/docview/2712846543
https://pubmed.ncbi.nlm.nih.gov/PMC9448351
https://doaj.org/article/032710f1e8a14cffb9eb4c53095dbd7f
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6xPSAuiKcIlGIkEKfs5uHECbdl26qXhRVbJG5W4kdZqU2qfVTqv--M46w2cOO2iidW4plZf3Y-fwPwyRRFppMiCmslbEiYPCw1kWlsntS5LnWiaMPtYim-_y5Oz0gmJ-vPwjjSvqpX4-b6Ztys_jhu5e2NmvQ8scliPitxTZFm8WQEI8SGB0v0DvMK0rXqSO5UhWdyOl_-GC_TvOQ5leFJcyo2QXVwD2YiJ9j_79_y31TJg7nn_Bk89aCRTbuHew6PTPMCHs_9Z_GXcIdAztNc71lrWdWwqerKQrBZx0VnnTQ5WzVs0UmpbhjtwTJPidl8ZVNGpMJ7tli32xbjw_XEflaNbjEYjO67usaflxS3r-DX-dnl7CL0BRVCham3DXlhuFUJt7G2VaKEFlWaGp4prkplM2u5iqywNENlmal1ESVGKLdEqlMETulrOGraxrwBRsqBNuY6iirOjY2qUsSapPRLFWPXSQCf-8GVt51uhsT1BvlDkj-k90cA32jk9zakdu0utOsr6X0uozRBIGRjU1QxV9bWpam5ylKEh7rWwgbwgfwmu6Oj-5yVU4F4kb58FgF8cRaUtehHVfnDB_gypH81sDweWOIAq2FzHxvSZ_tG4tMhLCRh_gA-7pvpTmKwNabdORtEAnSSNwAxiKnBuw9bMAGc4rcP-Lf_fec7eJLQuQ23d3QMR9v1zryH0UbvTtwuxInLoQdNayFk
link.rule.ids 230,315,729,782,786,866,887,2106,27933,27934,53800,53802
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB7RIgEX3ghDoYsE4uTEj7XX5hbSVkE0JSJB4ray9wGRWrvKA6n_npm1HcVw683yrle2Z8b77fqbbwDemyxLdJQFfqmE9QmT-7kmMo1NozLVuY4UbbhN5uLiZ3ZySjI5SZcL40j7qlwOqsurQbX87biV11dq2PHEhrPpOMc1RZyEwwO4i_EaBHuL9Ab1ClK2amjuVIdneDKdfxvM4zTnKRXiiVMqN0GVcPfmIifZ__-H-V-y5N7sc_bolvf9GB62cJONmuYncMdUT-HetP2h_gz-IARsCbI3rLasqNhINQUl2LhhsbNG1JwtKzZrRFjXjHZvWUumWX9iI0Z0xBs2W9WbGj3LjcS-F5Wu0Y2M7oa6xMMFefxz-HF2uhhP_LYUg68waDc-zwy3KuI21LaIlNCiiGPDE8VVrmxiLVeBFZbmtiQxpc6CyAjlFldljJArfgGHVV2Zl8BIc9CGXAdBwbmxQZGLUJMIf65CHDry4ENnFHndKG5IXKmQHSXZUbZ29OAzWWzXh3Sy3Yl69Uu2b10GcYQQyoYmK0KurC1zU3KVxAgsdamF9eCY7C2bpNNdtMuRQKRJ_0wzDz66HhTvaH9VtGkL-DCknNXredTriS9Y9Zs7n5Ltd2It8e4QUJKkvwfvds10JXHfKlNvXR_EEJQD7IHo-WLv2fst6IJOK7x1uVe3vvIY7k8W03N5_uXi62t4EFH2h9uBOoLDzWpr3sDBWm_fugj8C4d2Nfk
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEB7RIlVcKE_VtNBFAnFy4sfaa3MLSaMiSIlIkbit7H1ApNaO8kDqv2dm7UQx3OBmeccr2zPj_Xb97TcAb0yWJTrKAr9UwvqEyf1cE5nGplGZ6lxHihbcLmfi6ns2uiCZnF2pL0faV-W8V93c9qr5T8etXNyq_pYn1p9OhjnOKeIk7C-07R_AfczZINqbqDfIV5C6VUN1p1o8_dFk9qU3i9Ocp1SMJ06p5ARVw90bj5xs_98f5z8Jk3sj0Pj4P-79ETxsYScbNCaP4Z6pnsDRpP2x_hR-IRRsibJ3rLasqNhANYUl2LBhs7NG3JzNKzZtxFhXjFZxWUuqWb1nA0a0xDs2XdbrGiPM9cS-FpWuMZyM3nZ1g4fXFPnP4Nv44np46bclGXyFybv2eWa4VRG3obZFpIQWRRwbniiucmUTa7kKrLA0xiWJKTU6xgjlJllljNArfg6HVV2ZE2CkPWhDroOg4NzYoMhFqEmMP1chdh158HbrGLlolDckzljIl5J8KVtfevCBvLazIb1sd6Je_pDtm5dBHCGUsqHJipAra8vclFwlMQJMXWphPTgnn8tm8-ku6-VAIOKkf6eZB--cBeU9xoAq2u0L-DCkoNWxPOtY4gtW3eZtXMn2e7GSeHcILEna34PXu2a6kjhwlak3zgaxBO0F9kB04rHz7N0WDEOnGd6G3Yt_vvIcjqajsfz88erTKTyIaBOIW4g6g8P1cmNewsFKb165JPwNMI84eQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Feasibility+of+an+Activity+Control+System+in+Patients+with+Diabetes%3A+A+Study+Protocol+of+a+Randomised+Controlled+Trial&rft.jtitle=Diabetes%2C+metabolic+syndrome+and+obesity&rft.au=Montagut-Mart%C3%ADnez%2C+Pedro&rft.au=Garc%C3%ADa-Arenas%2C+Jose+Joaquin&rft.au=Romero-L%C3%B3pez%2C+Matilde&rft.au=Rodr%C3%ADguez-Rodr%C3%ADguez%2C+Nicomedes&rft.date=2022-01-01&rft.issn=1178-7007&rft.eissn=1178-7007&rft.volume=15&rft.spage=2683&rft.epage=2691&rft_id=info:doi/10.2147%2FDMSO.S369464&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1178-7007&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1178-7007&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1178-7007&client=summon